tetano
Editor, Senior Moderator
Vaccine. 2013 Jun 26. pii: S0264-410X(13)00837-2. doi: 10.1016/j.vaccine.2013.06.047. [Epub ahead of print]
Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.
Girard MP, Tam JS, Pervikov Y, Katz JM.
Source
Unversity Paris-Diderot, French National Academy of Medicine, 16 rue Bonaparte, 75006 Paris, France. Electronic address: marc.girard36@wanadoo.fr.
Abstract
On January 24-26, 2013, the World Health Organization convened the first integrated meeting on "The development and clinical trials of vaccines that induce broadly protective and long-lasting immune responses" to review the current status of development and clinical evaluation of novel influenza vaccines as well as strategies to produce and deliver vaccines in novel ways. Special attention was given to the development of possible universal influenza vaccines. Other topics that were addressed included an update on clinical trials of pandemic and seasonal influenza vaccines in high-risk groups and vaccine safety, as well as regulatory issues.
Copyright ? 2013. Published by Elsevier Ltd.. All rights reserved.
PMID:
23810374
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23810374
Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.
Girard MP, Tam JS, Pervikov Y, Katz JM.
Source
Unversity Paris-Diderot, French National Academy of Medicine, 16 rue Bonaparte, 75006 Paris, France. Electronic address: marc.girard36@wanadoo.fr.
Abstract
On January 24-26, 2013, the World Health Organization convened the first integrated meeting on "The development and clinical trials of vaccines that induce broadly protective and long-lasting immune responses" to review the current status of development and clinical evaluation of novel influenza vaccines as well as strategies to produce and deliver vaccines in novel ways. Special attention was given to the development of possible universal influenza vaccines. Other topics that were addressed included an update on clinical trials of pandemic and seasonal influenza vaccines in high-risk groups and vaccine safety, as well as regulatory issues.
Copyright ? 2013. Published by Elsevier Ltd.. All rights reserved.
PMID:
23810374
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23810374